According to FutureWise analysis the market for leadless pacemakers in 2023 was US$ 260 million, and is expected to reach US$ 430 million by 2031 at a CAGR of 7.7%.
Pacemakers send small electrical pulses to the heart muscles in order to keep the heart rate stable or to stimulate the lower chambers. A catheter, a thin long tube, is used to implant leadless pacemakers. A catheter is inserted into the femoral vein through a very small incision in patients’ groin. This area is numbed with a local anesthetic. The doctor uses an X-ray machine to guide the catheter to patient’s heart. After inserting the catheter, doctor will place the pacemaker in the right ventricle. It is tested to ensure that the device has been properly installed and programmed. The catheter is removed and pressure is applied to the incision site in order to close it. Pacemaker technology has advanced rapidly, including rate and output, to allow non-invasive connection with devices and better battery technology to increase the pulse generator's life duration by a year.
Every year, more than one million cardiac pacemakers are implanted throughout the world with about 200,000 of those procedures taking place in the US alone. These numbers are predicted to rise as a result of the ageing population and rising pace indicators. Cardiac pacemaker technology has advanced rapidly since the first pacemaker was implanted in the 1950s. The implantation and administration of transvenous cardiac pacemakers have undergone a revolution and transformation due to advances in battery life, pacemaker lead quality, algorithmic programming, and rate responsiveness (TV-PPM). The Nanostim Leadless Cardiac Pacemaker and the Medtronic Micra Transcatheter Pacing System are the two leadless pacing systems that are currently available. Both of these pacing systems use a catheter delivery system to be inserted into the femoral vein, but they differ in terms of size, fixation to the heart, and responsiveness.
Request a Free Sample @ https://www.futurewiseresearch.com/healthcare-market-research/Leadless-Pacemakers-Market/202
Leadless Pacemakers Market Segmentation:
By Technology
- Micra Transcatheter Pacing System
- Nanostim Leadless Pacemakers
- Wireless Cardiac Simulation System
By Indication
- Atrial Fibrillation
- High Degree Atrioventricular Block
- Sinus node dysfunction
- Others
By End-user
- Hospitals
- ASCs
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Competitive Landscape in Leadless Pacemakers Market:
- Medtronics
- St. Jude Medical LLC (Abbott Laboratories)
- Biotronic
- Boston Scientific
- Edwards Lifesciences
- Sorin Group
- Vitatron
- Lepu Medical
- Terumo Corp.
Ask For Discount: https://www.futurewiseresearch.com/contact.aspx?rpt=202%20&type=discount
**Objectives of this Study: **
- To provide a comprehensive analysis of the Leadless Pacemakers Market By Technology, By Indication, By End user and By Region.
- To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
- To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
- To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Flexible Delivery Model:
- We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
- The customization services offered are free of charge with the purchase of any license of the report.
- You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com
FutureWise Research
Contact Person: Vinay Thaploo.
Email: sales@futurewiseresearch.com
Contact Number: Asia: +91 8605575209 | USA: +1 3477094931
Website: www.futurewiseresearch.com
